Description
A piperazine derivative with cardioprotective activity; reduces INa in mouse myocytes expressing the long QT syndrome 3 mutant sodium channel DKPQ, ventricular myocytes isolated from a canine model of heart failure, guinea pig ventricular myocytes exposed to hydrogen peroxide or anemone toxin-II, and HEK293 cells expressing human Nav1.5 channels (IC50s = 5.9-15 μM); reduces IKr in canine ventricular myocytes and HEK293 cells (IC50s = 11.5 and 14.4 μM, respectively); reduces clofilium-induced prolongation of the QTc interval and TdP in rabbits at 480 μg/kg per min; reduces interstitial collagen deposition as well as ANP, CTGF, BNP, and MMP-2 mRNA levels, and prevents left ventricular dilation in a mouse model of doxorubicin-induced cardiotoxicity,
Formal name: N-(2,6-dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazineacetamide, dihydrochloride
Synonyms: RS 43285
Molecular weight: 500.5
CAS: 95635-56-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Receptor Pharmacology||Research Area|Cardiovascular System|Heart|Arrhythmia